La Jolla, CA, United States of America

Natalie Roy

USPTO Granted Patents = 4 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2001-2011

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Natalie Roy

Introduction

Natalie Roy is a prominent inventor based in La Jolla, California. She has made significant contributions to the field of biomedical research, particularly in the area of apoptosis regulation. With a total of four patents to her name, her work has the potential to impact therapeutic strategies for various pathologic conditions.

Latest Patents

One of her latest patents focuses on screening assays for agents that alter the inhibitor of apoptosis (IAP) protein regulation of caspase activity. This invention explores the interaction between IAP proteins and caspases, which are crucial in the process of programmed cell death. The patent outlines methods for identifying agents that can modulate the activity of caspases in the presence of IAPs, thereby providing new avenues for reducing the severity of certain diseases. Additionally, it offers methods for enhancing the survival of cells ex vivo by altering the caspase inhibitory activity of IAPs.

Career Highlights

Throughout her career, Natalie Roy has worked with esteemed institutions such as the Burnham Institute and the Sanford-Burnham Medical Research Institute. Her research has been pivotal in advancing our understanding of cell death mechanisms and their implications in disease.

Collaborations

Natalie has collaborated with notable scientists, including John C. Reed and Quinn L. Deveraux. These partnerships have enriched her research and contributed to the development of innovative solutions in the field.

Conclusion

Natalie Roy's work exemplifies the impact of innovative research in the biomedical field. Her patents and collaborations highlight her commitment to advancing scientific knowledge and improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…